Kiniksa Pharmaceuticals International, plc
KNSA
Clasificación en acciones
#2955
Kiniksa Pharmaceuticals International, plc, a biopharmaceutical company,... Kiniksa Pharmaceuticals International, plc, a biopharmaceutical company, develops and commercializes medical therapies in the United States, the United Kingdom, and internationally. The company offers ARCALYST, an interleukin-1alpha and 1beta cytokine trap for the treatment of recurrent pericarditis, a chronic autoinflammatory cardiovascular disease and cardiac sarcoidosis. It also develops KPL-387, an investigational and fully human immunoglobulin G2 monoclonal antibody, which is Phase 2/3 clinical trial for the treatment of recurrent pericarditis; and KPL-116, a Fc-modified immunoglobulin G2 monoclonal antibody, which is in pre-clinical stage. The company was formerly known as Kiniksa Pharmaceuticals, Ltd. and changed its name to Kiniksa Pharmaceuticals International, plc in June 2024. Kiniksa Pharmaceuticals International, plc was incorporated in 2015 and is based in London, the United Kingdom.
Precio por acción
$79.61
Capitalización bursátil
$6.21B
Cambio (1 día)
1.30%
Cambio (1 año)
106.02%
País
GB
Comercio Kiniksa Pharmaceuticals International, plc (KNSA)
Categoría
Healthcare
EPS de Kiniksa Pharmaceuticals International, plc (KNSA)
EPS a fecha de June 2026 TTM: $1.07
Según los últimos informes financieros y el precio de las acciones de Kiniksa Pharmaceuticals International, plc, el EPS actual de la empresa (TTM) es $1.07. Al final del año 2023, la empresa tenía un EPS de $0.20 una disminución en comparación con al EPS de 2022, que fue de $2.64.
Historial de EPS de Kiniksa Pharmaceuticals International, plc desde 2016 hasta 2026
EPS al final de cada año
| Año | EPS | Cambiar |
|---|---|---|
| 2026 (TTM) | $1.07 | -278.33% |
| 2024 | $-0.60 | -400.00% |
| 2023 | $0.20 | -92.42% |
| 2022 | $2.64 | -214.78% |
| 2021 | $-2.30 | -11.88% |
| 2020 | $-2.61 | -12.71% |
| 2019 | $-2.99 | -14.33% |
| 2018 | $-3.49 | 74.50% |
| 2017 | $-2.00 | 170.27% |
| 2016 | $-0.74 | 0.00% |
EPS de empresas similares o competidoras
| Empresa | EPS | Diferencia de EPS | País |
|---|---|---|---|
| $2.41 | 125.23% |
US
|
|
| - | - |
SE
|
|
| - | - |
FR
|
|
| - | - |
IT
|
|
| $0.52 | -51.40% |
US
|
